´ëÇѺ´¸®ÇÐȸ (¿Â¶óÀÎ)2022³âµµ Á¦2Â÷ ¿¬¼ö±³À°(½Å°æº´¸®) : 2022-07-23±³À°ÀÏÀÚ : 2022-07-23
±³À°Àå¼Ò :
www.keymedi.com(¿Â¶óÀο¬¼ö±³À°)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)2022³âµµ Á¦2Â÷ ¿¬¼ö±³À°(½Å°æº´¸®)ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ
¿¬¶ôó : 02-795-3094
À̸ÞÀÏ :
ksphe@kams.or.kr ±³À°Á¾·ù : º´¸®°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í ´ëÇѺ´¸®ÇÐȸ ¹Ì³³È¸ºñ¾ø´Â ȸ¿ø(Àü¹®ÀÇ : 40,000¿ø/Àü°øÀÇ(±ºÀÇ°üÆ÷ÇÔ) : 25,000¿ø), ¹Ì³³È¸ºñ Àִ ȸ¿ø(Àü¹®ÀÇ : 70,000¿ø/Àü°øÀÇ(±ºÀÇ°ü Æ÷ÇÔ) : 50,000¿ø), ºñȸ¿ø Àü¹®ÀÇ(À¯°ü¾÷ü ¶Ç´Â ´Üü¼Ò¼Ó ºñȸ¿ø Æ÷ÇÔ) : 100,000¿ø/ ºñȸ¿ø Àü°øÀÇ(Á¶±³, ´ëÇпø»ý. ±ºÀÇ°üÆ÷ÇÔ) : 50,000¿ø/
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-23 keymedi.com 10:05~10:35 Session 1. Basic Neuropathology-Basic Histopathology in the CNS ÀÌ°æÈ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 06-23 keymedi.com 10:35~11:05 Session 1. Basic Neuropathology-Intraoperative Diagnosis of CNS tumors ±è³ª·¡(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 06-23 keymedi.com 11:05~11:45 Session 1. Basic Neuropathology-Commonly Encountered Problems in Daily Practice with CNS Cases ±Ç¹ÌÁ¤(ÇѸ²ÀÇ´ë)
Åä·Ð 06-23 keymedi.com 11:45~12:00 Session 1. Basic Neuropathology-Q&A ()
±³À°½Ã°£ 06-23 keymedi.com 13:00~13:30 Session 2. WHO Classification of the CNS Tumor Update- Introduction of 5TH Ed WHO Classification of the CNS Tumor ¹Ú¼ºÇý(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-23 keymedi.com 13:30~14:00 Session 2. WHO Classification of the CNS Tumor Update-Adult-Type Diffuse Glioma ³²¼öÁ¤(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-23 keymedi.com 14:00~14:30 Session 2. WHO Classification of the CNS Tumor Update- Pediatric-Type Diffuse Glioma ¿øÀç°æ(¼¿ïÀÇ´ë)
Åä·Ð 06-23 keymedi.com 14:30~14:50 Session 2. WHO Classification of the CNS Tumor Update-Q&A ()
±³À°½Ã°£ 06-23 keymedi.com 15:00~15:30 Session 3. Molecular Neuropathology- Molecular Diagnostics of the CNS Tumor À̺¸¶÷(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06-23 keymedi.com 15:30~16:00 Session 3. Molecular Neuropathology- Practical Approach to the Diagnosis of the CNS Tumor in the Era of 5TH Ed WHO Classification ¼¿¬¸²(¼º±Õ°üÀÇ´ë)
Åä·Ð 06-23 keymedi.com 16:00~16:20 Session 3. Molecular Neuropathology-Q&A ()